key: cord-0770116-aytklh2y
authors: Matava, Clyde; Collard, Vincent; Siegel, Jeffrey; Denning, Simon; Li, Tianyuan; Du, Bowen; Fiadjoe, John; Fiset, Pierre; Engelhardt, Thomas
title: Use of a high-flow extractor to reduce aerosol exposure
date: 2020-07-28
journal: Br J Anaesth
DOI: 10.1016/j.bja.2020.07.014
sha: 6889252051c83db960d0f0388b144a369986e3d6
doc_id: 770116
cord_uid: aytklh2y

nan

Editor -SARS-CoV-2 transmission is thought to be through fomites, droplets and droplet nuclei 25 (aerosols) 1 . Aerosol-generating medical procedures are commonly performed and are associated with increased risk of infection of healthcare workers 2 . Some clinicians are using barriers such as transparent plastics and Plexiglas boxes to reduce aerosol spread [3] [4] [5] [6] [7] . However, these barriers may limit access to the patient and mobility of the clinician 8 . An alternative to barriers that may reduce aerosol spread is directed high flow air extraction. A high flow air extractor combines 30 high flow suction and a high-efficiency particulate (HEPA) filter. We conducted a study to determine if high flow air extraction reduces aerosol exposure of clinicians. We designed an experimental model that determined the efficacy of removal of particles similar in size to human aerosols. We used two particles to simulate aerosols, essential oil particles ranging in size from 1 nm to 1 micron, and ISO 12103-1 A1 Ultrafine test dust (Powder Technologies Inc, city, state, USA) ranging in size from 1-20 microns. We simulated human breathing using an essential oil 5 diffuser as a continuous aerosol source.

Human cough aerosols range in size from 0.58-5.42 microns, with 80% in the 0.74-2.12 microns Our primary outcome was to determine the reduction of aerosols at the source. A 99% reduction in the aerosol concentration near the source would be consistent with the Centre for Disease Prevention and Control's (CDC) requirements for air exchanges between patient encounters 10 .

Secondary outcomes included reduction of aerosol concentrations at the level of the clinician's head with the high-flow air extractor 'on' during a cough and an obstructed cough. The 10 effectiveness, H, was calculated by subtracting the ratio of 'high-flow air extractor on' to 'highflow air extractor off' mean particle concentration measured by each aerosol quantification device from unity.

The high-flow extractor device was 99% effective at removing aerosols near the source resulting 15 in no levels detected at the clinician's head (Figure 1a and Supplementary 3 -video). During an uncovered cough, the high-flow extractor had a 97% effectiveness in reducing the aerosols detected near the clinician's head (Figure 1b) . In these first two scenarios aerosols were effectively removed at source and did not contaminate the room or the reach the clinician's head.

However, when the cough was covered by the provider's hand there was only a 52% reduction in 20 aerosols detected at the clinician's head; the absolute concentration was very low due to less aerosols reaching the clinician's head as a result of covering the cough (Figure 1c) . The covered cough resulted in a higher concentration of aerosols at sensors placed lateral to the patient (Supplementary 4). This was likely because aerosols were diverted away from the device's intake but subsequently reached the clinician's head. The effectiveness of the high-flow air extractor was high for larger particles (> 1 micron) emitted from the simulated cough, and generally low for small particles (< 1 micron) (Supplementary 5 A, B) .

Our study shows that a high-air flow extractor is effective in removing aerosols during simulated 5 continuous breathing and a simulated cough. However, simply covering a cough with a gloved hand resulted in the escape of aerosols and subsequent detection at the clinician's head.

Removal of aerosols may enhance the safety of healthcare workers and improve operational efficiencies. Currently, a minimal air exchange rate of 15 -20 per h is recommended for operating room air decontamination. At this rate 18 -28 min is required to reduce airborne 10 contaminants by 99% 10 . This delay causes workflow inefficiencies and the extractor can be used to accelerate air decontamination. We acknowledge the contributions of Theo Tackey, Rachelle and Jesse Matava

The authors declare no that they have no conflicts of interest. simulated cough test and (b) simulated covered cough test. There is little difference in the clearance of particle sizes PM 1 (particles with an aerodynamic diameter less than 0.1 micrometers) and PM 2.5 , (particles with an aerodynamic diameter less than 2.5 micrometers). Calculated HFE effectiveness is labeled on top of each pair of boxes/bars during (a) essential oil diffuser test; (b) simulated cough test; (c) simulated covered cough test. In (a), the boxes represent the first and third quartiles, the line in the boxes represents the median, the whiskers represent 1.5 times the interquartile range. Concentrations outside of the whiskers are excluded for visual clarity. In (b) and (c), the bars represent the mean concentrations during the tests. 10

John Fiadjoe -Children's Hospital of Philadelphia

Harshad Gurnaney -Children's Hospital of Philadelphia

Aerosol and Surface Stability of SARS-15

CoV-2 as Compared with SARS-CoV-1

Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review

Clear plastic drapes may be effective at limiting aerosolization 20 and droplet spray during extubation: implications for COVID-19

A multipurpose portable negative air flow isolation chamber for aerosol-generating procedures during the COVID-19 pandemic

Effectiveness of a negative-pressure patient isolation 25 hood shown using particle count

The aerosol box for intubation in COVID-19 patients: an in-situ simulation crossover study

Comparison of three tracheal intubation methods for reducing droplet spread for use in COVID-19 patients

More on Barrier Enclosure during Endotracheal Intubation

The size and concentration of droplets generated by coughing in human subjects

Guidelines for preventing the 35 transmission of Mycobacterium tuberculosis in health-care settings

 5